Financials data is unavailable for this security.
View more
Year on year Elliptic Laboratories ASA 's revenues fell -23.20% from 131.91m to 101.31m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 8.96m to a loss of 138.17m.
| Gross margin | -- |
|---|---|
| Net profit margin | -82.32% |
| Operating margin | -8.33% |
| Return on assets | -38.28% |
|---|---|
| Return on equity | -43.30% |
| Return on investment | -41.75% |
More ▼
Cash flow in NOKView more
In 2025, cash reserves at Elliptic Laboratories ASA fell by 33.33m. However, the company earned 5.99m from its operations for a Cash Flow Margin of 5.92%. In addition the company used 26.86m on investing activities and also paid 10.31m in financing cash flows.
| Cash flow per share | -0.8383 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 1.80 |
|---|---|
| Tangible book value per share | 1.12 |
More ▼
Balance sheet in NOKView more
| Current ratio | 5.61 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.0691 |
|---|---|
| Total debt/total capital | 0.0646 |
More ▼
